| 1 | Study | 1.98% | |
| 2 | New | 1.48% | |
| 3 | Risk | 0.99% | |
| 4 | Patients | 0.99% | |
| 5 | Alzheimer’s | 0.74% | |
| 6 | Cancer | 0.74% | |
| 7 | May | 0.74% | |
| 8 | Brain | 0.74% | |
| 9 | Prostate | 0.74% | |
| 10 | Therapy | 0.49% | |
| 11 | Patient | 0.49% | |
| 12 | Mitral | 0.49% | |
| 13 | Valve | 0.49% | |
| 14 | Learning | 0.49% | |
| 15 | Kidney | 0.49% | |
| 16 | COVID-19 | 0.49% | |
| 17 | Protein | 0.49% | |
| 18 | mRNA | 0.49% | |
| 19 | Your | 0.49% | |
| 20 | AI | 0.49% | |
| 21 | Dementia | 0.49% | |
| 22 | Biomarker | 0.49% | |
| 23 | Artery | 0.49% | |
| 24 | Gene | 0.49% | |
| 25 | Asia | 0.49% | |
| 26 | Care | 0.49% | |
| 27 | Safety | 0.49% | |
| 28 | Muscle | 0.49% | |
| 29 | COPD | 0.49% | |
| 30 | Pain | 0.49% | |
| 31 | US | 0.49% | |
| 32 | Researchers | 0.49% | |
| 33 | Cell | 0.49% | |
| 34 | Chronic | 0.49% | |
| 35 | Tertiary | 0.49% | |
| 36 | Era | 0.49% | |
| 37 | Test | 0.49% | |
| 38 | Stroke | 0.49% | |
| 39 | Metabolic | 0.49% | |
| 40 | Cardiobacterium | 0.25% | |
| 41 | Hypopituitarism | 0.25% | |
| 42 | Guillain-Barre | 0.25% | |
| 43 | Approval | 0.25% | |
| 44 | ‘Ozempic | 0.25% | |
| 45 | Across | 0.25% | |
| 46 | Investigational | 0.25% | |
| 47 | Cause | 0.25% | |
| 48 | Their | 0.25% | |
| 49 | Composition | 0.25% | |
| 50 | CKD | 0.25% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
FDA grants orphan drug status to ISX9-CPC for heart issues in DMD
Muscular Dystrophy News
2025-06-06 05:06:48